Epithelializing Stent for Benign Prostatic Hyperplasia: A Systematic Review of the Literature

Journal of Urology

Volumn 177, Issue 5, 2007, Pages 1619-1624

  Armitage, J N ^a   Cathcart, P J ^a   Rashidian, A ^a   De Nigris, E ^a   Emberton, M ^a,b   van der Meulen, J H P ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b INSTITUTE OF UROLOGY AND NEPHROLOGY   (United Kingdom)

Author keywords

prostate; prostatic hyperplasia; prostheses and implants; stents; urinary bladder neck obstruction

Indexed keywords

BLADDER OBSTRUCTION; DEVICE; EPITHELIZATION; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MALE; MICTURITION; OUTCOMES RESEARCH; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVIEW; SCORING SYSTEM; STENT; SYSTEMATIC REVIEW; TRANSURETHRAL RESECTION; TREATMENT FAILURE;

HUMANS; MALE; PROSTATIC HYPERPLASIA; PROSTHESIS IMPLANTATION; STENTS; TREATMENT OUTCOME; URINARY BLADDER NECK OBSTRUCTION; UROLOGIC SURGICAL PROCEDURES, MALE;

EID: 34147153413     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.01.005     Document Type: Review

References (40)

1. Fabian K.M. The intra-prostatic "partial catheter" (urological spiral). Urol Ausgabe A 19 (1980) 236
2. Armitage J.N., Rashidian A., Cathcart P.J., Emberton M., and van der Meulen J.H. The thermo-expandable metallic stent for managing benign prostatic hyperplasia: a systematic review. BJU Int 98 (2006) 806
3. Donnell R.F. Urethral stents in benign prostate hyperplasia. Curr Urol Rep 4 (2003) 282
4. Kapoor R., Liatsikos E.N., and Badlani G. Endoprostatic stents for management of benign prostatic hyperplasia. Curr Opin Urol 10 (2000) 19
5. Lam J.S., Volpe M.A., and Kaplan S.A. Use of prostatic stents for the treatment of benign prostatic hyperplasia in high-risk patients. Curr Urol Rep 2 (2001) 277
6. Oesterling J.E. Benign prostatic hyperplasia. Medical and minimally invasive treatment options. N Engl J Med 332 (1995) 99
7. Ogiste J.S., Cooper K., and Kaplan S.A. Are stents still a useful therapy for benign prostatic hyperplasia?. Curr Opin Urol 13 (2003) 51
8. van Dijk MM and de la Rosette JJMCH: Prostatic stents in the treatment of benign prostatic hyperplasia. Global Surgery. Available at http://www.touchbriefings.com. Accessed on June 13, 2006.
9. Downs S.H., and Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52 (1998) 377
10. Khan K.S., ter Riet G., Popay J., Nixon J., and Kleijnen J. Undertaking systematic reviews of research on effectiveness: CRD's guidance for those carrying out or commissioning reviews (2001), Centre for reviews and dissemination, York. http://www.york.ac.uk/inst/crd/report4.htm Available at http://www.york.ac.uk/inst/crd/report4.htm. Accessed August 10, 2006.
11. Lohr K.N. Rating the strength of scientific evidence: relevance for quality improvement programs. Int J Qual Health Care 16 (2004) 9
12. Adam A., Jäger R., McLoughlin J., el-Din A., Machan L., Williams G., et al. Wallstent endoprostheses for the relief of prostatic urethral obstruction in high risk patients. Clin Radiol 42 (1990) 228
13. Amón-Sesmero J.H., Martínez-Sagarra-Oceja J.M., Estebanez Z.J., Rodríguez T.A., Del Río D.F., Velasco M.C., et al. Permanent endoprostatic prostheses in patient with obstruction caused by benign hyperplasia of the prostate. Actas Urol Esp 22 (1998) 490
14. Bajoria S., Agarwal S.A., White R., Zafar F., and Williams G. Experience with the second generation UroLume prostatic stent. Br J Urol 75 (1995) 325
15. Bellinzoni P., Guazzonni G., Montorsi F., Bergamaschi F., Consonni P., and Rigatti P. Transrectal hyperthermia versus transrectal thermotherapy versus UroLume wallstent: comparative evaluation of one year follow-up in patients with benign prostatic hyperplasia at high operative risk. Acta Urol Ital 7 suppl (1993) 129
16. Clemente R.L., Burgos-Revilla F.J., Fernández F.E., Jiménez C.M., Cruz G.N., and Escudero B.A. Efficacy and complications of intraprostatic prosthesis in the treatment of benign hyperplasia of the prostate. Arch Esp Urol 50 (1997) 773
17. Comeri G., Conti G., Cretarola E., Furgoni P., and Gianneo E. Role of urodynamics in implantation of prostatic stents. Arch Ital Urol Androl 67 (1995) 81
18. Goepel M., Senge A., Otto T., and Rübben H. Long-term results of wall stent implantation in benign prostatic hyperplasia and high risk status. Urologe A 36 (1997) 151
19. Guazzoni G., Montorsi F., and Rigatti P. The use of wallstents in patients with benign prostatic hyperplasia. Arch Esp Urol 47 (1994) 927
20. Guazzoni G., Montorsi F., Coulange C., Milroy E., Pansadoro V., Rubben H., et al. A modified prostatic UroLume Wallstent for healthy patients with symptomatic benign prostatic hyperplasia: a European Multicenter Study. Urology 44 (1994) 364
21. Martorana G., Oneto F., Banchero R., Pacella M., Gogna P., Avio M., et al. Intraprostatic prosthesis in the therapy of benign prostatic hypertrophy. Acta Urol Ital 7 suppl (1993) 347
22. Masood S., Djaladat H., Kouriefs C., Keen M., and Palmer J.H. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia. BJU Int 94 (2004) 1271
23. Milroy E., and Chapple C.R. The UroLume stent in the management of benign prostatic hyperplasia. J Urol 150 (1993) 1630
24. Oesterling J.E., Kaplan S.A., Epstein H.B., Defalco A.J., Reddy P.K., Chancellor M.B., and The North American UroLume Study Group. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. Urology 44 (1994) 353
25. Scarpone P., Emiliozzi P., Florio A., and Pansadoro V. Permanent endourethral prothesis in the treatment of cervico-prostatic obstruction with high surgical risk: preliminary data. Acta Urol Ital, suppl. 6 (1992) 107
26. Williams G., Coulange C., Milroy E.J., Sarramon J.P., and Rubben H. The urolume, a permanently implanted prostatic stent for patients at high risk for surgery. Results from 5 collaborative centres. Br J Urol 72 (1993) 335
27. ™ endoprosthesis for the treatment of benign prostatic hyperplasia in inoperable patients. J Urol 151 suppl (1994) 396A abstract 675
28. Chapple C.R., Rosario D.J., Wasserfallen M., Woo H.H., Nordling J., and Milroy E.J.G. A randomized study of the UroLume stent versus prostatic surgery. J Urol 153 suppl (1995) 436A
29. ™ endoprosthesis in the treatment of benign prostatic hypertrophy (BPH): urodynamic results. J Urol 151 suppl (1994) 397A
30. Shapiro C.E., and Brusky J.P. Early experience with Urolume endoprosthesis in 10 cases. J Endourol 18 suppl (2004) A91
31. Yip K.H., Lee F., Lam P.C., and Ho K.K. Urolume prostatic stents for urinary retention due to benign prostatic hyperplasia in patients with high medical risks. Hong Kong Med J 3 (1997) 136
32. Flanigan R.C., Reda D.J., Wasson J.H., Anderson R.J., Abdellatif M., and Bruskewitz R.C. 5-year outcome of surgical resection and watchful waiting for men with moderately symptomatic benign prostatic hyperplasia: a Department of Veterans Affairs cooperative study. J Urol 160 (1998) 12
33. AUA Guideline on the Management of Benign Prostatic Hyperplasia: Diagnosis and Treatment Recommendations. Available at http://www.auanet.org/timssnet/products/guidelines/main_reports/bph_management/chapt_1_appendix.pdf. Accessed August 10, 2006.
34. Madersbacher S. Stents for prostatic diseases: any progress after 25 years?. Eur Urol 49 (2006) 212
35. Schneider H.J., De S.J.V., and Palmer J.H. The Urolume as a means of treating urinary outflow obstruction and its impact on waiting lists. Br J Urol 73 (1994) 181
36. Anjum M.I., Chari R., Shetty A., Keen M., and Palmer J.H. Long-term clinical results and quality of life after insertion of a self-expanding flexible endourethral prosthesis. Br J Urol 80 (1997) 885
37. Defalco A., Oesterling J.E., Epstein H., Gainesville F.L., and North American UroLume Study Group. The North American experience with the UroLume endourethral prosthesis as a treatment for BPH: 3-year results. J Urol 153 suppl (1995) 436A
38. Shah D.K., Kapoor R., Badlani G.H., and North American Study Group. Experience with urethral stent explantation. J Urol 169 (2003) 1398
39. Marinkovic S., Badlani G., and North American Multicenter Trial Group. Seven year outcome analysis of the UroLume stent for benign prostatic hyperplasia. J Endourol 13 suppl (1999) A79
40. Corujo M., and Badlani G.H. Epithelialization of permanent stents. J Endourol 11 (1997) 477